SCHEMBL22529289

SCHEMBL22529289

CCOC1C(=O)c2c(OCc3ccccc3)cc(OCc3ccccc3)cc2OC1c1ccc(OCc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ PDE4A P27815 1/20 0.38
▸ PDE4B Q07343 1/20 0.38
▸ PDE4C Q08493 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ ABCB1 P08183 5/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ NTSR1 P30989 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6078672 0.93 ALDH1A1 (0.41) ALDH1A1MEN1KMT2APDE4APDE4B
SCHEMBL5264350 0.93 ALDH1A1 (0.41) ALDH1A1MEN1KMT2APDE4APDE4B
SCHEMBL14427922 0.87 ALDH1A1 (0.45) ALDH1A1MEN1KMT2APDE4APDE4B
SCHEMBL7242379 0.84 ALDH1A1 (0.57) ALDH1A1MEN1KMT2AL3MBTL1MAPK1
SCHEMBL10609388 0.82 ABCB1 (0.58) ALDH1A1MEN1KMT2APDE4APDE4B
Quercetin Pentaethyl Ether SCHEMBL8656505 0.81 MEN1 (0.55) ALDH1A1MEN1KMT2AMAPK1KDM4E
SCHEMBL25438234 0.80 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AABCB1KDM4E
SCHEMBL25438233 0.80 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AABCB1KDM4E
SCHEMBL10608985 0.80 ALDH1A1 (0.67) ALDH1A1MEN1KMT2APDE4APDE4B
SCHEMBL14427921 0.72 STING1 (0.43) ALDH1A1MEN1KMT2APDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200323814-A1 MEDICAL COMPOUND VERA SALUS RICERCA S.R.L. (IT) 2020-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200323814-A1 MEDICAL COMPOUND MTNR1B, CBR1, MTNR1A ALDH1A1 470/4885MEN1 591/4885KMT2A 3998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback